Trump's Capitol Hill whisperer reveals secrets to president's dealmaking as he heads for exit - Fox News #Trump #CapitolHill #Politics #Dealmaking #FoxNews
@politicsdaily.bsky.social
@politicsdaily.bsky.socialTrump's Capitol Hill whisperer reveals secrets to president's dealmaking as he heads for exit - Fox News #Trump #CapitolHill #Politics #Dealmaking #FoxNews
@politicsdaily.bsky.socialTrump's Capitol Hill whisperer reveals secrets to president's dealmaking as he heads for exit #Trump #Politics #CapitolHill #Dealmaking #FoxNews
@hobbyspeculators.bsky.socialTurns out the person who always gets screwed in a deal is often painted as the bad guy. If you agree to a $50k deal that then jumps to $100k, and payment is delayed, only to be blamed for wanting to renegotiate to $75k. It's a wild spin. #negotiation #dealmaking
@markfortner.bsky.socialReal-time insights into drug pipelines are crucial for evaluating risk & understanding vision. Pharm2Market’s AI news agents deliver company profiles, KDMs, funding history & more.
Streamline deal-sourcing at beta.pharm2market.app/.
@thedealroom.bsky.socialKnowing the Numbers Isn't Enough: Order Is Everything in a Deal
#TheDealRoom #DealSurgeon #CapitalCommander #Legacy #DealMaking
@aspenbio.bsky.socialReal-time insights into drug pipelines are crucial for evaluating risk & understanding vision. Pharm2Market’s AI news agents deliver company profiles, KDMs, funding history & more.
Streamline deal-sourcing at beta.pharm2market.app/.
@markfortner.bsky.socialReal-time insights into drug pipelines are crucial for evaluating risk & understanding vision. Pharm2Market’s AI news agents deliver company profiles, KDMs, funding history & more.
Streamline deal-sourcing at beta.pharm2market.app/.
@aspenbio.bsky.socialReal-time insights into drug pipelines are crucial for evaluating risk & understanding vision. Pharm2Market’s AI news agents deliver company profiles, KDMs, funding history & more.
Streamline deal-sourcing at beta.pharm2market.app/.
@pharmaphorum.bsky.socialA #survey of senior figures in #Europeanbiopharma companies has found that #dealmaking and M&A are expected to increase, with some suggesting that this will be helped by policy uncertainties in the US.
@frontpagestoday.bsky.social"Hopes for record year in dealmaking punctured by interest rate increases"
By Oliver Barnes & Ivan Levingston
Financial Times — Monday 5 October 🔍
The report presents a measured accounting of a contraction in global corporate acquisitions,…
@markfortner.bsky.socialReal-time insights into drug pipelines are crucial for evaluating risk & understanding vision. Pharm2Market’s AI news agents deliver company profiles, KDMs, funding history & more.
Streamline deal-sourcing at beta.pharm2market.app/.
@pharmaphorum.bsky.social#EliLilly has continued a busy period of #dealmaking with a wide-ranging #partnership with #China's #InnoCarePharma that includes upfront and near-term payments of $100 million.
@markfortner.bsky.socialReal-time insights into drug pipelines are crucial for evaluating risk & understanding vision. Pharm2Market’s AI news agents deliver company profiles, KDMs, funding history & more.
Streamline deal-sourcing at beta.pharm2market.app/.
@aspenbio.bsky.socialReal-time insights into drug pipelines are crucial for evaluating risk & understanding vision. Pharm2Market’s AI news agents deliver company profiles, KDMs, funding history & more.
Streamline deal-sourcing at beta.pharm2market.app/.
@kill-bait.bsky.socialTalkTalk explores consumer arm with Ares as Opus deal stalls
🤖 IA: It's not clickbait ✅
👥 Users: It's not clickbait ✅
#talktalk #telecoms #dealmaking
👇👇👇
@markfortner.bsky.socialReal-time insights into drug pipelines are crucial for evaluating risk & understanding vision. Pharm2Market’s AI news agents deliver company profiles, KDMs, funding history & more.
Streamline deal-sourcing at beta.pharm2market.app/.
@aspenbio.bsky.socialReal-time insights into drug pipelines are crucial for evaluating risk & understanding vision. Pharm2Market’s AI news agents deliver company profiles, KDMs, funding history & more.
Streamline deal-sourcing at beta.pharm2market.app/.
@craigofwaffles.bsky.socialCarbon capture has been active again the past few weeks in #dealmaking and project starting. Is there a new factor adding interest in #CCUS? Third item in the Chem Biz Watch this week is a Messer CO2 terminal in the EU.
cen.acs.org/business/bus...